Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Children's Hospital of Orange County Hospital, Orange, California University of Minnesota, Minneapolis, Minnesota Atlantic Health System, Morristown, New Jersey University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania University or Texas, Southwestern medical Center, Dallas, Texas